Symposium:
038. Mano-a-Mano III: Controversies in Pediatric ID
Thursday, October 5, 2017: 10:30 AM-12:00 PM
Room: 20ABCD

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the use of Fluconazole vs. micafungin for neonatal candidiasis
  • describe pathogen based vs. symptom-based isolation for pediatric inpatients
  • discuss the pros and cons of RSV prophylaxis

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Investigators, Medical students and residents, Members-in-training, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists, Vaccinologists

Tracks: Pediatric ID, Trainee, Epidemiology and Infection Control


Chair:  Archana Chatterjee, MD, PhD, FIDSA, FPIDS, University of South Dakota Sanford School of Medicine/Sanford Children's Specialty Clinic

Moderators:  Ravi Jhaveri, MD, FIDSA, FPIDS, University of North Carolina and Andi L. Shane, MD, MPH, MSc, FIDSA, FPIDS, Emory University School of Medicine

Presentations:
10:30 AM
115
10:45 AM
116
11:00 AM
117
Pathogen-Based Isolation for Pediatric Inpatients
Thomas J. Sandora, MD, MPH, FSHEA

11:15 AM
118
Symptom-Based Isolation for Pediatric Inpatients
Andi L. Shane, MD, MPH, MSc, FIDSA, FPIDS

11:45 AM
120
RSV Prophylaxis Guidelines Should Be Revised
Asuncion Mejias, MD, PhD, MsCS

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-246-L01-P

Disclosures:

A. Chatterjee, None

R. Jhaveri, None

A. L. Shane, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.